Hemodynamic effects of the somatostatin analog lanreotide in humans: Placedo-controlled, cross-over dose-ranging echo-doppler study

Hepatology

Volumn 27, Issue 4, 1998, Pages 920-925

  Mottet, Christian ^a   Sieber, Cornel C ^a   Nauer, Andre ^a   Drewe, Jürgen ^a   Fried, Ronald ^a   Larsen, Finn ^b   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b IPSEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; PLACEBO; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY VASCULAR RESISTANCE; MALE; NORMAL HUMAN; PORTAL HYPERTENSION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLANCHNIC BLOOD FLOW;

ADULT; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; HEMODYNAMIC PROCESSES; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; PEPTIDES, CYCLIC; SOMATOSTATIN; SPLANCHNIC CIRCULATION;

EID: 0031943329     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270405     Document Type: Article

References (20)

1. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N. Randomized double-blind placebo controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388-1395.
2. Silvain C, Carpentier S, Sautereau D, Czernnichow B, Métreau JM, Fort E, Ingrand P, et al. Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from oesophageal varices: a multicenter randomized trial. HEPATOLOGY 1993;18:61-65.
3. Sung JJY, Chung SCS, Lau CWL, Chan FKL, Leung JWC, Yung ME, Kassianides C, et al. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993;342:637-641.
4. Feu F, Del Arbol LR, Banares R, Planas R, Bosch J, and members of the variceal bleeding study group. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1996;111:1291-1299.
5. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992;103:229-234.
6. Erikkson LS, Brundin T, Söderlund C, Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-925.
7. McCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, Burroughs AK. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990;2: 489-492.
8. Mountokalakis T, Kallivretakis N, Mayopoulou-Symvoulidou D, Karvountzis G, Tolis G. Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis. Nephrol Dial Transplant 1988;3:604-607.
9. Berthold H, del Pozo E. Antidiuretic effect of sandostatin (SMS 201-995) in healthy volunteers. Acta Endocrinologica 1989;120:708-714.
10. Gines A, Salmeron JM, Gines P, Jimenez W, Salo J, Piera C, Claria J, et al. Effects of somatostatin on renal function in cirrhosis. Gastroenterology 1992;103:1868-1874.
11. Rodriguez-Perez F, Albillos A, Groszmann RJ. Octreotide improves renal function, total exchangeable sodium and peripheral haemodynamics in cirrhotic patients with ascites. Gastroenterology 1993;104:980A.
12. Escorsell A, Bandi JC, Francois E, Moitinho E, Andreu V, Palacios A, Garcia-Pagan JC, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. HEPATOLOGY 1996;24:207A.
13. Moneta GL, Taylor DC, Helton WS, Mulholland MW, Strandness DE Jr. Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition. Gastroenterology 1988;95:1294-1301.
14. Jger K, Bollinger A, Valli C, Ammann R. Measurement of mesenteric blood flow by Duplex scanning. J Vasc Surg 1986;3:462-469.
15. Sieber C, Beglinger C, Jaeger K, Hildebrand P, Stalder GA. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut 1991;32:361-366.
16. Sabba C, Ferraioli G, Buonamico P, Mahl T, Lerner E, Taylor KJW, Groszmann RJ. A randomized study of propranolol on post-prandial portal hyperemia in cirrhotic patients. Gastroenterology 1992;102:1002-1016.
17. Lee S, Hadengue A, Moreau R, Hillon P, Lebrec D. Post-prandial hemodynamic responses in patients with cirrhosis. HEPATOLOGY 1988;8: 647-651.
18. Castleman L, Brandt JL, Ruskin H. The effect of oral feeding of meat and glucose on hepatic vein wedge pressure in normal and cirrhotic subjects. J Lab Clin Med 1958;51:897-903.
19. McCormick PA, Dick R, Graffeo M, Wagstaff D, Madden A, McIntyre N, Burroughs AK. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. J Hepatol 1990;11: 221-225.
20. Cooper AM, Braatvedt GD, Qamar MI, Brown H, Thomas DM, Halliwell M, Read AE, et al. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci 1991:81:169-175.